Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands.
Sex Transm Infect. 2022 Sep;98(6):395-400. doi: 10.1136/sextrans-2021-055227. Epub 2021 Oct 29.
Pre-exposure prophylaxis (PrEP) use may influence sexual behaviour and transmission of STIs among men who have sex with men (MSM). We aimed to quantify the distribution of STI diagnoses among MSM in the Netherlands based on their sexual behaviour before and after the introduction of PrEP. HIV-negative MSM participating in a prospective cohort study (Amsterdam Cohort Studies) completed questionnaires about sexual behaviour and were tested for STI/HIV during biannual visits (2009-2019). We developed a sexual behaviour risk score predictive of STI diagnosis and used it to calculate Gini coefficients for gonorrhoea, chlamydia and syphilis diagnoses in the period before (2009 to mid-2015) and after PrEP (mid-2015 to 2019). Gini coefficients close to zero indicate that STI diagnoses are homogeneously distributed over the population, and close to one indicate that STI diagnoses are concentrated in individuals with a higher risk score. The sexual behaviour risk score (n=630, n visits=10 677) ranged between 0.00 (low risk) and 3.61 (high risk), and the mean risk score increased from 0.70 (SD=0.66) before to 0.93 (SD=0.80) after PrEP. Positivity rates for chlamydia (4%) and syphilis (1%) remained relatively stable, but the positivity rate for gonorrhoea increased from 4% before to 6% after PrEP. Gini coefficients increased from 0.37 (95% CI 0.30 to 0.43) to 0.43 (95% CI 0.36 to 0.49) for chlamydia, and from 0.37 (95% CI 0.19 to 0.52) to 0.50 (95% CI 0.32 to 0.66) for syphilis comparing before to after PrEP. The Gini coefficient for gonorrhoea remained stable at 0.46 (95% CI 0.40 to 0.52) before and after PrEP. MSM engaged in more high-risk sexual behaviour and gonorrhoea diagnoses increased after PrEP was introduced. Chlamydia and syphilis diagnoses have become more concentrated in a high-risk subgroup. Monitoring the impact of increasing PrEP coverage on sexual behaviour and STI incidence is important. Improved STI prevention is needed, especially for high-risk MSM.
暴露前预防(PrEP)的使用可能会影响男男性行为者(MSM)的性行为和性传播感染(STI)的传播。我们旨在根据 MSM 在 PrEP 引入前后的性行为来量化荷兰 MSM 中的 STI 诊断分布。参与前瞻性队列研究(阿姆斯特丹队列研究)的 HIV 阴性 MSM 完成了性行为问卷,并在每半年一次的访问期间接受了 STI/HIV 检测(2009-2019 年)。我们开发了一个性行为风险评分,用于预测 STI 诊断,并使用该评分计算了淋病、衣原体和梅毒诊断的基尼系数,这些诊断是在 PrEP 引入之前(2009 年至 2015 年年中)和之后(2015 年年中至 2019 年)进行的。基尼系数接近零表示 STI 诊断在人群中均匀分布,接近一表示 STI 诊断集中在风险评分较高的个体中。性行为风险评分(n=630,n 访问=10677)范围为 0.00(低风险)至 3.61(高风险),PrEP 前风险评分平均值为 0.70(SD=0.66),PrEP 后为 0.93(SD=0.80)。衣原体(4%)和梅毒(1%)的阳性率保持相对稳定,但淋病的阳性率从 PrEP 前的 4%增加到 PrEP 后的 6%。淋病的基尼系数从 PrEP 前的 0.37(95%CI 0.30 至 0.43)增加到 0.43(95%CI 0.36 至 0.49),梅毒的基尼系数从 PrEP 前的 0.37(95%CI 0.19 至 0.52)增加到 0.50(95%CI 0.32 至 0.66)。淋病的基尼系数在 PrEP 前后保持稳定,为 0.46(95%CI 0.40 至 0.52)。PrEP 引入后,MSM 进行了更多的高风险性行为,淋病诊断增加。衣原体和梅毒诊断在高危亚组中更加集中。监测 PrEP 覆盖率增加对性行为和 STI 发病率的影响非常重要。需要改进 STI 预防,特别是针对高危 MSM。